Design and optimization of ganciclovir solid dispersion for improving its bioavailability

Abstract

Development of new approaches for oral delivery of an existing antiviral drug aimed to enhance its permeability and hence bioavailability. Ganciclovir (GC) is an antiviral drug that belongs to class III in biopharmaceutical classification. The encapsulation of poorly absorbed drugs within nanosized particles offers several characteristics to drug due to their acquired surface properties. In the following study, the solvent evaporation technique was used to incorporate GC, within elegant nanosize particles using cyclodextrin and shellac polymers for enhancing its permeability and release pattern. Formulation variables were optimized using 2 3 full factorial design. The prepared formulations were assessed for yield, particle size, content, and micromeritics behavior. The optimized formula (F6) was identified through differential scanning calorimetry and Fourier transform infrared. In vitro release and stability were also assessed. Pharmacokinetic parameters of optimized nano GC solid dispersion particles (NGCSD-F6) were finally evaluated. The optimized formula (F6) showed a mean particle size of 288.5 ± 20.7 nm, a zeta potential of about 23.87 ± 2.27, and drug content 95.77 ± 2.1%. The in vitro drug release pattern of F6 showed an initial burst release followed by a sustained release over the next 12 h. The optimized formula showed accepted stability upon storage at room and refrigerator temperatures for 6 months with good flowing properties (Carr’s index = 18.28 ± 0.44). In vivo pharmacokinetic study in rabbits revealed 2.2 fold increases in the bioavailability of GC compared with commercial convention tablets. The study affords evidence for the success of the solid dispersion technique under specified conditions in improvement of bioavailability of GC.

Nanophytosome formulation of β-1,3-glucan and Euglena gracilis extract for drug delivery applications

“…The BG-PC and EG-PC exhibited spherical distinct vesicles at scale of 100 nm. The entrapment efficiency of the NPs, BG-PC and EG-PC were found to be 82 ± 1.62 and 87 ± 3.22 % respectively which is considered optimum for enhancing bioavailability [31] . With all optimization the NPs represent prominent physical and chemical characterizations, however, few limitations of the study include analyzing the in vitro drug release profile of NPs which is essential to study the release profile over time duration which plays pivotal role in biological system.…”

Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A

“…Carr’s index was commonly used to indicate the flowability of dry powders [ 41 , 42 ], with values of <25 suggesting good flowability and >40 indicating poor flowability. Carr’s index values of CsA-SD and CsA-LEU were all >45, indicating poor flowability, and the values of the formulations with HPMC were in the range of 28–32, indicating an improvement in flowability.…”

Formulation and evaluation of Piroxicam nanosponge for improved internal solubility and analgesic activity

“…4.11, Malvern Instruments, UK). All PXM-NS formulations were suspended in deionized water for assessment (Gaber et al., 2022b ).…”